Silo Pharma, Inc. (SILO)

Silo Pharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	3.52	11.37	9.84	1.13	0.11
Short-Term Investments	4.14	0.07	0.42	0.02	0.21
Cash & Cash Equivalents	7.67	11.44	10.26	1.15	0.32
Cash Growth	-32.97%	11.50%	790.30%	258.74%	-43.16%
Inventory	0	0	0	0	0.16
Other Current Assets	0.02	0.14	0.15	0.27	0.02
Total Current Assets	7.68	11.57	10.4	1.43	0.49
Long-Term Investments	0	0	0.06	0	0
Other Long-Term Assets	0.06	0.07	0.03	0	0
Total Long-Term Assets	0.06	0.07	0.09	0	0
Total Assets	7.75	11.64	10.49	1.43	0.49
Accounts Payable	0.7	0.36	0.42	0.13	0.05
Deferred Revenue	0.87	0.94	1.01	0	0
Current Debt	0	0	0	0.01	0.06
Other Current Liabilities	-0.79	-0.87	-0.94	0	0
Total Current Liabilities	0.78	0.44	0.49	0.14	0.12
Long-Term Debt	0	0	0	0	0
Other Long-Term Liabilities	0.79	0.87	0.94	0	0
Total Long-Term Liabilities	0.79	0.87	0.94	0	0
Total Liabilities	1.57	1.3	1.43	0.15	0.12
Total Debt	0	0	0	0.02	0.06
Debt Growth	-	-	-	-69.45%	176.92%
Retained Earnings	-10.87	-7.17	-3.26	-5.76	-2.66
Comprehensive Income	-0.01	0	0	0	0
Shareholders' Equity	6.18	10.34	9.06	1.28	-0.02
Net Cash / Debt	7.67	11.44	10.26	1.13	0.26
Net Cash / Debt Growth	-32.97%	11.50%	805.14%	337.07%	-52.22%
Net Cash Per Share	2.49	5.01	5.35	0.86	0.55
Working Capital	6.91	11.14	9.91	1.28	0.38
Book Value Per Share	2.01	4.53	4.78	0.97	-0.05

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).